Search research articles
Contact Us
Filters
Showing results (1111-1120 of 1,342) with videos related to
Page
of 135
Sort By:
Leukemia & Lymphoma
|
July 24, 2018
Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases
Artur Jurczyszyn, Julio Davila, K Martin Kortüm, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
June 23, 2012
Iron and vitamin status biomarkers and its association with physical fitness in adolescents: the HELENA study
Luis Gracia-Marco, Jara Valtueña, Francisco B Ortega, et al.
British Journal of Haematology
|
July 4, 2019
CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib
Jorge J Castillo, Lian Xu, Joshua N Gustine, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
January 7, 2023
Implication of chromosomal microarray analysis prior to in-utero repair of fetal open neural tube defect
R Zemet, E Krispin, R M Johnson, et al.
Hemasphere
|
August 18, 2020
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic
Dipti Talaulikar, Ranjana H Advani, Andrew R Branagan, et al.
Neurologia (Barcelona, Spain)
|
December 18, 2010
[Stroke health care plan (ICTUS II. 2010)]
J Masjuan, J Alvarez-Sabín, J Arenillas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 29, 2019
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
N Tarazona, F Gimeno-Valiente, V Gambardella, et al.
Blood Cancer Journal
|
April 15, 2025
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis
Y Sawalha, S Sarosiek, R L Welkie, et al.
Leukemia
|
July 4, 2015
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia
I M Ghobrial, R Redd, P Armand, et al.
Blood
|
April 26, 2024
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia
Eric Durot, Damien Roos-Weil, Adrien Chauchet, et al.
Page
of 135
Search research articles
Search
Showing results (1111-1120 of 1,342) with videos related to
Sort By:
Page
of 135
Leukemia & Lymphoma
|
July 24, 2018
Multiple myeloma in patients up to 30 years of age: a multicenter retrospective study of 52 cases
Artur Jurczyszyn, Julio Davila, K Martin Kortüm, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)
|
June 23, 2012
Iron and vitamin status biomarkers and its association with physical fitness in adolescents: the HELENA study
Luis Gracia-Marco, Jara Valtueña, Francisco B Ortega, et al.
British Journal of Haematology
|
July 4, 2019
CXCR4 mutation subtypes impact response and survival outcomes in patients with Waldenström macroglobulinaemia treated with ibrutinib
Jorge J Castillo, Lian Xu, Joshua N Gustine, et al.
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology
|
January 7, 2023
Implication of chromosomal microarray analysis prior to in-utero repair of fetal open neural tube defect
R Zemet, E Krispin, R M Johnson, et al.
Hemasphere
|
August 18, 2020
Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic
Dipti Talaulikar, Ranjana H Advani, Andrew R Branagan, et al.
Neurologia (Barcelona, Spain)
|
December 18, 2010
[Stroke health care plan (ICTUS II. 2010)]
J Masjuan, J Alvarez-Sabín, J Arenillas, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 29, 2019
Targeted next-generation sequencing of circulating-tumor DNA for tracking minimal residual disease in localized colon cancer
N Tarazona, F Gimeno-Valiente, V Gambardella, et al.
Blood Cancer Journal
|
April 15, 2025
Outcomes of patients with relapsed/refractory lymphoplasmacytic lymphoma/waldenström macroglobulinemia treated with venetoclax: a multicenter retrospective analysis
Y Sawalha, S Sarosiek, R L Welkie, et al.
Leukemia
|
July 4, 2015
Phase I/II trial of everolimus in combination with bortezomib and rituximab (RVR) in relapsed/refractory Waldenstrom macroglobulinemia
I M Ghobrial, R Redd, P Armand, et al.
Blood
|
April 26, 2024
High efficacy of CD19 CAR T cells in patients with transformed Waldenström macroglobulinemia
Eric Durot, Damien Roos-Weil, Adrien Chauchet, et al.
Page
of 135